Document Detail

Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience.
MedLine Citation:
PMID:  20701434     Owner:  NLM     Status:  In-Process    
OBJECTIVE: Infliximab (IFX) is a well-established treatment for both acute, severe ulcerative colitis (UC) and chronic, refractory UC. However, data on the long-term clinical outcome and colectomy rates after IFX treatment in a routine clinical setting are sparse. The aim of this study was to provide further data on the long-term effect of IFX for acute, severe and chronic, refractory UC in unselected patients treated at a single center.
MATERIAL AND METHODS: A retrospective analysis of all patients (n = 52) treated with IFX for UC before February 2009 was performed. The material comprised 19 patients (37%) with acute, severe UC and 33 patients (63%) with chronic, refractory UC. The primary outcome was colectomy rate; the secondary outcome clinical response.
RESULTS: The overall colectomy rate was 27% (14/52 patients) after a median follow-up of 22 months (range 4-57 months). The colectomy rate was 37% (7/19 patients) in the group with acute, severe UC and 21% (7/33 patients) among those with chronic, refractory UC. In all, 77% of the patients had clinical response to IFX treatment with no difference between the two subgroups. Among those with an initial clinical response, 50% (20/40 patients) had sustained clinical response.
CONCLUSION: IFX is of long-term benefit as rescue treatment in selected patients with acute, severe UC with about two-thirds of the patients avoiding colectomy. The beneficial effect on colectomy rate in chronic, refractory UC seems less convincing although these patients may still achieve a sustained clinical response.
Ane Søgaard Teisner; Mark A Ainsworth; Jørn Brynskov
Related Documents :
8574734 - Omeprazole-based antimicrobial therapies: results in 198 helicobacter pylori-positive p...
7876994 - Gastric emptying in children with gastric transposition.
18989994 - Irsogladine is effective for recurrent oral ulcers in patients with behçet's disease :...
23290674 - Determination and communication of critical findings in neuroradiology.
16741554 - Upper gastrointestinal bleeding in a patient with aids.
8574734 - Omeprazole-based antimicrobial therapies: results in 198 helicobacter pylori-positive p...
Publication Detail:
Type:  Journal Article     Date:  2010-08-11
Journal Detail:
Title:  Scandinavian journal of gastroenterology     Volume:  45     ISSN:  1502-7708     ISO Abbreviation:  Scand. J. Gastroenterol.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0060105     Medline TA:  Scand J Gastroenterol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1457-63     Citation Subset:  IM    
Department of Gastroenterology, Medical Section, Herlev Hospital, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Epidemiology of gastroduodenal erosions in the general population: endoscopic results of the systema...
Next Document:  An elevated fetal interleukin-6 concentration can be observed in fetuses with anemia due to Rh alloi...